TABLE 4

FROM:

Low expression of -glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype

K Kawakami, A Ooyama, A Ruszkiewicz, M Jin, G Watanabe, J Moore, T Oka, B Iacopetta and T Minamoto

Table 4. Associations between mRNA expression level and the concentration of folate intermediates in CRC from an Australian cohort

	CH 2 FH 4		FH 4
Gene symbol	Spearman's	P-value	Spearman's	P-value
CDA	0.205	0.063	0.154	0.163
DCK	0.058	0.583	0.056	0.599
DCTD	-0.042	0.684	0.024	0.817
DHFR	-0.081	0.448	-0.145	0.174
DPYD	0.020	0.845	0.010	0.924
DUT	-0.022	0.834	-0.022	0.834
ECGF1	0.062	0.559	0.043	0.686
FOLR1	-0.136	0.190	-0.073	0.481
FPGS	-0.025	0.807	0.023	0.822
GGH	-0.200	0.053	-0.180	0.083
MTHFD1	-0.014	0.856	-0.033	0.752
MTHFR	-0.028	0.784	0.037	0.720
RFC1	-0.159	0.123	-0.205	0.046
RRM1	0.039	0.707	0.006	0.952
RRM2	0.107	0.303	0.046	0.661
TYMS	0.076	0.471	-0.018	0.864
UMPS	-0.121	0.246	-0.050	0.630

 CRC=colorectal cancer.

 Spearman's rank correlation test was used for analyses.

 Spearman's and P-value are presented for each analysis of correlations.